US equities
|
MU
$937.33
▼-5.23%
META
$761.45
▲+2.49%
NVDA
$227.21
▲+0.39%
SNDK
$1,448.55
▼-2.61%
AAPL
$343.07
▲+0.62%
SPCX
$157.46
▼-3.65%
MSFT
$546.48
▲+0.98%
AMD
$597.00
▲+0.46%
MU
$937.33
▼-5.23%
META
$761.45
▲+2.49%
NVDA
$227.21
▲+0.39%
SNDK
$1,448.55
▼-2.61%
AAPL
$343.07
▲+0.62%
SPCX
$157.46
▼-3.65%
MSFT
$546.48
▲+0.98%
AMD
$597.00
▲+0.46%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Veracyte, Inc. - Common Stock
(NQ:
VCYT
)
43.59
-0.44 (-0.99%)
Delayed Quote
Updated: 1:37 PM EDT, Oct 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Veracyte, Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know
↗
May 07, 2021
Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday. ARKF shed 298,505 Apple...
Via
Benzinga
Veracyte Announces New Data Relating to Prosigna Breast Cancer Test to Be Presented at ESMO Breast Cancer Virtual Congress
May 04, 2021
From
Veracyte, Inc.
Via
Business Wire
Veracyte to Unveil Practice-Changing Genomic Diagnostics Data Across Multiple Oncology Indications at 2021 ASCO
April 29, 2021
From
Veracyte, Inc.
Via
Business Wire
Veracyte Announces Publication of Study Showing Robust Performance of Percepta GSC in Improving Lung Cancer Diagnosis
April 27, 2021
From
Veracyte, Inc.
Via
Business Wire
Veracyte to Release First Quarter 2021 Financial Results on May 10, 2021
April 20, 2021
From
Veracyte, Inc.
Via
Business Wire
Veracyte Announces Data for Pulmonology Portfolio to be Presented at American Thoracic Society 2021 International Conference
April 19, 2021
From
Veracyte
Via
Business Wire
54 Biggest Movers From Friday
↗
April 19, 2021
Gainers Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) shares surged 73.9% to close at $31.30 on Friday after the company priced its IPO at $18 per share. General Finance...
Via
Benzinga
Topics
Initial Public Offering
The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs
↗
April 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Ardelyx, Inc. (NASDAQ:...
Via
Benzinga
Veracyte Announces Retirement of CFO and Preliminary First Quarter 2021 Financial Results
April 15, 2021
From
Veracyte, Inc.
Via
Business Wire
Veracyte Announces Key Milestone in Companion Diagnostics Program With Acerta Pharma Using LymphMark Lymphoma Subtyping Test
April 14, 2021
From
Veracyte
Via
Business Wire
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
